Primary Care Providers’ Beliefs and Recommendations and Use of Screening Mammography by their Patients
Authors:
- on behalf of the PROSPR (Population-based Research Optimizing Screening through Personalized Regimens) consortiumOCon behalf of the PROSPR (Population-based Research Optimizing Screening through Personalized Regimens) consortium
- Jennifer S. HaasJHJennifer S. Haas
- 9 January 2017
- journal article
- research article
- Published by Springer Nature in Journal of General Internal Medicine
- Vol. 32 (4) , 449-457
Abstract
Background Revised breast cancer screening guidelines have fueled debate about the effectiveness and frequency of screening mammography, encouraging discussion between women and their providers. Objective To examine whether primary care providers’ (PCPs’) beliefs about the effectiveness and frequency of screening mammography are associated with utilization by their patients. Design Cross-sectional survey data from PCPs (2014) from three primary care networks affiliated with the Population-based Research Optimizing Screening through Personalized Regimens (PROSPR) consortium, linked with data about their patients’ mammography use (2011–2014). Participants PCPs (n = 209) and their female patients age 40–89 years without breast cancer (n = 30,233). Main Measures Outcomes included whether (1) women received a screening mammogram during a 2-year period; and (2) screened women had >1 mammogram during that period, reflecting annual screening. Principal independent variables were PCP beliefs about the effectiveness of mammography and their recommendations for screening frequency. Key Results Overall 65.2% of women received >1 screening mammogram. For women 40–48 years, mammography use was modestly lower for those cared for by PCPs who believed that screening was ineffective compared with those who believed it was somewhat or very effective (59.1%, 62.3%, and 64.7%; p = 0.019 after controlling for patient characteristics). Of women with PCPs who reported they did not recommend screening before age 50, 48.1% were nonetheless screened. For women age 49–74 years, the vast majority were cared for by providers who believed that screening was effective. Provider recommendations were not associated with screening frequency. For women ≥75 years, those cared for by providers who were uncertain about effectiveness had higher screening use (50.7%) than those cared for by providers who believed it was somewhat effective (42.8%). Patients of providers who did not recommend screening were less likely to be screened than were those whose providers recommended annual screening, yet 37.1% of patients whose providers recommended against screening still received screening. Conclusions PCP beliefs about mammography effectiveness and screening recommendations are only modestly associated with use, suggesting other likely influences on patient participation in mammography.Keywords
This publication has 25 references indexed in Scilit:
- Development and Evaluation of a Decision Aid on Mammography Screening for Women 75 Years and OlderJAMA Internal Medicine, 2014
- Trends in mammography screening rates after publication of the 2009 US Preventive Services Task Force recommendationsCancer, 2013
- Talking About Stopping Cancer Screening—Not So Easy Comment on “Older Adults and Forgoing Cancer Screening: ‘I Think It Would be Strange’”JAMA Internal Medicine, 2013
- Targeting of Mammography Screening According to Life Expectancy in Women Aged 75 and OlderJournal of the American Geriatrics Society, 2013
- Mammography Screening for Breast CancerNew England Journal of Medicine, 2012
- The association between general practitioners’ attitudes towards breast cancer screening and women’s screening participationBMC Cancer, 2012
- Screening for Breast Cancer: U.S. Preventive Services Task Force Recommendation StatementAnnals of Internal Medicine, 2009
- Breast cancer risk assessment and management in primary care: Provider attitudes, practices, and barriersCancer Detection Prevention, 2007
- Preventive Care for Women -- Does the Sex of the Physician Matter?New England Journal of Medicine, 1993
- A new method of classifying prognostic comorbidity in longitudinal studies: Development and validationJournal of Chronic Diseases, 1987